Key statistics
On Tuesday, Ackermans & Van Haaren NV (0GYM:LSE) closed at 264.80, -0.60% below its 52-week high of 266.40, set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 266.50 |
|---|---|
| High | 264.80 |
| Low | 264.80 |
| Bid | 251.00 |
| Offer | 277.40 |
| Previous close | 263.70 |
| Average volume | 13.31k |
|---|---|
| Shares outstanding | 33.16m |
| Free float | 21.59m |
| P/E (TTM) | 16.33 |
| Market cap | 8.81bn EUR |
| EPS (TTM) | 16.27 EUR |
| Annual div (ADY) | 3.80 EUR |
|---|---|
| Annual div yield (ADY) | 1.44% |
| Div ex-date | May 29 2025 |
| Div pay-date | Jun 02 2025 |
Data delayed at least 20 minutes, as of Feb 10 2026 12:36 GMT.
More ▼
- Ackermans & van Haaren Trading Update 3Q25: uitstekende resultaten van de kernparticipaties, FY2025 vooruitzichten bevestigd
- Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed
- Ackermans & van Haaren trading update 3T2025: excellents résultats des participations principales, perspectives 2025 confirmées
- Ackermans & van Haaren invests 22 million euros in VKC Nuts
- Ackermans & van Haaren investeert 22 miljoen euro in VKC Nuts
- Ackermans & van Haaren investit 22 millions d'euros dans VKC Nuts
- Ackermans & van Haaren ondersteunt de serie B-financieringsronde van 55 miljoen euro van MRM Health
- Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros
- Ackermans & van Haaren soutient le tour de financement de série B de 55 millions d’euros de MRM Health
- Ackermans & van Haaren investeert 20 miljoen US dollar in het tweede fonds van Venturi Partners
More ▼
